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1. Introduction
  Chikungunya fever (CHIK) outbreak was observed in 
India in December 2005. Phylogenetic analysis of the 
isolated virus showed a central-east African strain that was 
closely related to the strain from the Reunion Islands[1]. 
Historically, the first outbreak of CHIK was reported in 
1963 in Kolkata, and the last reported outbreak occurred 
in 1973 in Maharashtra. The reemergence of the virus may 
have been facilitated by human population migrations 
in the Indian Ocean region. Chikungunya wave spread 
to tropical part of Africa, America and Asia[2]. In India 
first outbreak was recorded in Kolkata in 1963 followed 
by east coastal area like Chennai, Pondichery, Vellore 
and Vishakapattanam in 1964.Later it was recorded in 
1965 in central part of India, i.e, Rajmundri, Kakinada 
and Nagpur Since December 2005, cases of CHIK were 
reported from several Indian states including Andhra 
Pradesh, Maharashtra, Karnataka, TamilNadu, and Madhya 
Pradesh[3]. With one of the best healthcare systems in India 
Kerala’s status has received a severe blow in the past one 
year due to the outbreak of chikungunya viral fever in 
the state. Last year, more than 100 people died during the 
outbreak of the mosquito-borne viral fever in the coastal 
districts of Alappuza, Kollam and Ernakulam. The present 
outbreak, which has seen more than 40 people die in the 
past two weeks in the south and central districts of Kollam, 
Pathanamthitta, Kottayam and parts of the capital city has 
raised questions about how good Kerala’s healthcare system 
really is[4]. According to sources, more than 100 000 people 
are down with fever in the south and central districts of 
the state and the disease is now spreading to the northern 
districts as well chikungunya, is caused by an arbovirus 
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and transmitted by Aedes aegypti (A. aegypti)mosquito[5].
  Chikungunya virus (CHIKV) is a mosquito-transmitted 
Alphavirus belonging to family Togaviridae. It was isolated 
for the first time from a Tanzanian outbreak in 1952[6]. 
It is responsible for an acute infection of abrupt onset, 
characterized by high fever, arthralgia, myalgia, headache, 
and rash. Poly-arthralgia, the typical clinical sign of the 
disease, is very painful. Symptoms are generally self-
limiting and last 1-10 days. However, arthralgia may persist 
for months or years. In some patients, minor hemorrhagic 
signs such as epistaxis or gingivorrhagia have also been 
described. CHIK-V is geographically distributed in 
Africa, India, and South-East Asia. In Africa, the virus is 
maintained through a sylvatic transmission cycle between 
wild primates and mosquitoes such as Aedes luteocephalus, 
A. furcifer, or A. taylori[7].  In Asia, CHIK-V is transmitted 
from human to human mainly by A. aegypti and, to a lesser 
extent, by A. albopictus through an urban transmission 
cycle. Since the 1952 Tanzania outbreak, CHIK-V has 
caused outbreaks in East Africa (Tanzania and Uganda), 
in Austral Africa (Zimbabwe and South Africa), in West 
Africa (Senegal and Nigeria), and in Central Africa (Central 
African Republic and Democratic Republic of the Congo). 
The most recent epidemic reemergence was documented 
in 1999-2000 in Kinshasa, where an estimated 50 000 
persons were infected[8]. Since the first documented Asian 
outbreak in 1958 at Bangkok, Thailand, outbreaks have 
been documented in Thailand, Cambodia, Vietnam, Laos, 
Myanmar, Malaysia, Philippines, and Indonesia. The most 
recent epidemic re-emergence was documented in 2001-
2003 in Java, after 20 years. In both Africa and Asia, the re-
emergence was unpredictable, with intervals of 7-8 years to 
20 years between consecutive epidemics[9]. Since the end of 
2004, CHIKV has emerged in the islands of the south-western 
Indian Ocean. Between January and March 2005, more than 
5 000 cases were reported in Comoros. Later in 2005, the virus 
has circulated in the other islands, i.e, Mayotte, Seychelles, 
Re´union, and Mauritius. Starting in December 2005, the 
rainy season gave rise to a renewed epidemic circulation 
of the virus. Since January 1, 2006, several thousands cases 
were reported in each of Mayotte, Mauritius, and Seychelles 
islands[10]. The most affected island is Re´union (total 
population:770 000), with an estimated 244 000 cases (16 
April, 2006). More recently, circulation of the virus has also 
been documented in Madagascar and in India. In Re´union 
Island, the first documented cases were patients coming 
back from Comoros in March 2005. More than 3 000 cases 
were reported from March to June[11]. Transmission was 
limited (50-100 cases per week) during the winter season of 
the southern hemisphere, and a major upsurge was observed 
from mid-December, with an estimated 12 400 cases in 2005 
and an estimated 231 600 cases in 2006 (16 April, 2006).The 
peak incidence in 2006 was observed during the second 
week of February, with more than 45 000 cases. The number 
of cases has now decreased, with an estimated 3 000 cases 
during the second week of April. Since March 2005, 123 
patients with a confirmed CHIKV infection have developed 
severe clinical signs (neurological signs or fulminant 
hepatitis) that justified hospitalization in an intensive care 
unit[12].
  The name, chickungunya comes from the Swahili which 
means “bends up”, reflecting the physique of a person 
suffering from the disease. It resembles Dengue and is 
reported mainly from Africa, South-East Asia including 
India and Pakistan. It occurs principally during the rainy 
season. Chikungunya outbreaks typically result in large 
number of cases but deaths are rarely encountered. The 
human infections are acquired by the bite of infected Ae. 
aegypti mosquitoes, which are day biters and epidemics 
are sustained by human-mosquito-human transmission[13]. 
These mosquitoes usually breed in clean water collections 
in containers, tanks, disposables, junk materials in 
domestic and pre-domestic situations. Symptoms of 
infection generally last for three to seven days after the 
patient has been bitten by the infected mosquito. After an 
incubation period of 4-7 days, there is a sudden onset of flu-
like symptoms including fever, chills, headache, nausea, 
vomiting, severe joint pain (arthralgia) and rash. Rash may 
appear at the outset or several days into the illness; its 
development often coincides with defervescence, which 
takes place around day 2 or day 3 of the disease. The rash 
is most intense on trunk and limbs and may desquamate. 
Migratory polyarthritis usually affects the small joints. The 
joints of the extremities in particular become swollen and 
painful to the touch. Although rare, the infection can result 
in meningoencephalitis (swelling of the brain), especially in 
newborns and those with pre-existing medical conditions. 
Pregnant women can pass the virus to their fetus[14]. 
Haemorrhage is rare and all but a few patients recover 
within 3-5 days. Residual arthritis, with morning stiffness, 
swelling and pain on movement may persist for weeks or 
months after recovery. A full blown disease is most common 
among adults, in whom the clinical picture may be dramatic. 
Severe cases of chikungunya can occur in the elderly, in 
the very young (newborns) and in those who are immuno 
compromised[15].
  Recent outbreak of chikungunya in some southern states 
of India, Kerala in particular is alarming. The number 
of chikungunya cases in Kerala, India has followed an 
increasing trend since 2005. Outbreak of chikungunya began 
for the first time in 2006 affecting nearly 70 000 persons from 
14 districts and in May 2007, another outbreak surfaced 
affecting almost all districts. Hence an attempt was made to 
understand the burden of chikungunya in our locality based 
on different factors. 
2. Materials and methods
  Oral consent was obtained from the authorities of various 
hospitals and individuals prior to study. The criteria for 
selection of the districts were based on the confirmed cases 
reported by Kerala state health authorities. Recently more 
cases were reported from northern part of Kerala than 
southern states which prompted us to undertake the study 
in northern parts of Kerala, where our AL Shifa College of 
Pharmacy is located. Assessibility to the hospitals made our 
work easier. Suspected cases of chikungunya were identified 
based on the clinical symptoms guidelines given by state 
health authorities. Personal data such as name age, sex, 
location, date of onset of illness, medical history, general/
systemic examination features, drugs used (in Allopathic, 
Ayurveda, Homeopathy, Traditional) for the treatment 
etc were noted down. We undertook the study to analyze 
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the burden and magnitude of chikungunya in both indoor 
and outdoor patients in various primary health center, 
government hospitals and private hospitals in our locality. 
This was a six month descriptive study and 209 suspected 
cases were identified from July to December 2009. During 
these six months detailed history was taken from the case 
history, and personal interview of doctors and suspected 
cases.
  Kerala being very strong in traditional systems of 
medicines like Ayurveda, Unani and Siddha and since we 
have plenty of herbal medicines in our basket, we undertook 
the study to explore the knowledge of doctors in various 
system of medicines and to understand the different drugs 
used in these systems for the treatment of chikungunya. 
A simple questionnaire was prepared and distributed to 
various doctors practicing various systems of medicines. 
A close ended, simple to understand, and comprehensive 
question format was deliberately designed to keep away 
any inadvertent bias interpreting specific responses. Each 
questionnaire had all questions with two options. Since it 
was an open ground survey, the doctors were asked to fill 
details such as name qualification, consulting address. 
Doctors were clearly informed that the survey was a formal 
assessment and not related to their final grade. Only 
descriptive analysis was recorded.
  Intensity of chikungunya was determined on the basis of 
frequency of symptoms in patients. Those symptoms with 
more than 80% were considered with mark 3 intensity, 
those having more than 70% but not more than 80% were 
considered as mark 2 intensity. Symptoms with 50% to 70% 
cases were considered as mark 1 intensity. Symptoms less 
than 50% are excluded.
  Finally all the data were critically analyzed and tabulated.
3. Results 
  In this study, out of 209 suspected cases, 99(47.36%) were 
in the age group of 20-40 years, 77(36.84%) were in the age 
group of 40-60 years, 17 (8.13%) were in the age group of 60-
80 years, 13 (6.22%) were in  the age group of 10-20 years 
and 3(1.43%) in the age group of 80 and above. A total of 
144(68.69%) patients were females and 65 out of 209(31.11%) 
were males. The study revealed that females were more 
affected than males. A total of 150 (71.77%) were from rural 
area and 59 (28.23%) were from urban area.The Grade-III 
(58.73%) population were more prone to chikungunya than 
Grade-II (38.75%) and Grade-I (2.87%). It showed that fever, 
pain in muscles, sleeping disturbances were the intense 
symptoms of chikungunya. Rashes were intense symptoms 
with 2 mark intensity. Unilateral ankle pain and pain in 
wrist joints were symptom with one mark intensity (Figure 1). 
  Myocarditis and arthritis were concomitant diseases 
which worsen chikungunya symptoms. In the present 
study arthritis worsen the condition in 6.69% of patients 
and myocarditis 0.47%. It also indicated that the effective 
medicine for compliance is nonsteroidal antiinflammatory 
drugs (NSAIDS) (pain killers) and most doctors prefer NSAIDS 
for the treatment of chikungunya rather than steroidal 
preparations (Figure 2). It revealed that 66.5% took more than 
one month for recovery, 19.13% took two months period and 
8.61% took 1-2 weeks and  5.74% recovered within one week. 
And the maximum case 98% were found in outdoor patients.
  The drugs used in treatment and prevention of chikungunya 
with homeopathy were Euphatorium, Pyrogen, China, 
Nuxvomica, Gelsimium, Rhus Tox., Arnica, Belladona, 
Bryonia, and Ars alb. In systematic homeopathy, Rhustox- 
tid, Ledumpal –qid, Balladona–qid, Bryonia-qid were used 
for acute cases, and rhusto暳200 bid, Ledumpal 200 bid were 
used in prevention for 7 days. And 70-80% were relieved 
in 5 days. The drugs used in treatment and prevention of 
Chickungunya by ayurvedic method of medication were 
Amruthadiguggulu (1 gm tds), Rasnaeranda kwatha churna 
(15 mL tds), Vanathulasi patra, Beruenna(oil), Vilwadi 
gulika (tab), Sudarshana tablet, Vettumaran gulika., and 
Amruthotharam kashayam. Five doctors consulted assurred 
the prevention of chickengunya by homeopathy and 
ayurveda, and they were of the opinion that homeopathy 
treatment and ayurveda were more effective than modern 
medicine. All doctors were aware about the efficacy and 
adverse effects of drugs used in ayurveda, and 60% were 
aware about homeopathy. 
Figure 1.  Symptomatalogy of chikungunya.                                    
                                                                
Figure 2.  Drug related parameters.  
4. Discussion
  With one of the best healthcare systems in India, Kerala 
status has received a severe blow in the recent years due to 
the outbreak of chickungunya viral fever in the state. Many 
people died and suffered during the outbreak of the mosquito 
borne viral fever in the coastal districts of Alappuza, kollam 
and Ernakulam. The present outbreak of chikungunya in 
many parts of Kerala has raised questions about how good 
Kerala healthcare system really is. According to sources, 
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more than 10 000 people are down with fever in the south and 
central districts of the state and the disease is now spreading 
to the northern districts as well. The number of chikungunya 
cases in Kerala, India, has followed an increasing trend 
since 2005. From our survey, which was done in a systemic 
manner with respect to age, it was found that people in the 
age group of 20-40 years were more affected than the older 
age. This shows that older generation are more cautious 
in taking the precautions in terms of hygiene as well as 
preventing the entry of mosquitoes into the place of living 
by closing the windows at right time, installing the wire 
meshes at the doorway windows which helps in aeration 
but prevents the entry of mosquitoes. In respect to gender 
wise distribution, females were found to be more prone to 
chikungunya due to staying more in waterborne area (like 
cleaning washing etc) and also it may be due to biological 
difference. Rural area accounts for more number of cases. 
Most of the places, good hygienic conditions were not been 
maintained. Contaminated water from the household had 
not been disposed off properly due to which it has become 
a breeding center for mosquitoes. Socio-economic factors 
also have an impact on chickungunya. Most cases, increase 
in temperature, muscular pain and sleep disturbances, 
were found to be major symptoms. Patients with the above 
mentioned symptoms were not able to carryout the daily 
routine procedure or job which affected them economically 
too. In this regard, the treatment regimens followed by the 
physicians were found to be administration of analgesics 
and antipyretics followed by rest for a minimum period of 
1-2 weeks. In very few cases, arthritis and myocarditis were 
reported. Very few patients were advised to take steroids. 
With respect to recovery time, few patients recovered 
with in one week and most of the patients took almost one 
month time to recover and such patients were from the rural 
area. This shows the severity of the conditions. The study 
revealed that most patients went to primary health centre 
and government hospitals for the treatment of chickungunya 
and majority were found to be outdoor patients. The reason 
in avoiding private hospitals may be due to lack of interest 
in taking the costly medication provided by corporate sector 
hospital.
4.1. Chikungunya treatment in Ayurveda
  Ayurveda is traditional Indian medicine and also is a 
popular alternative medicine in India. Ayurveda medicines 
are usually natural drugs and hence with few side effects. 
Our findings revealed that, since there is no new medicine 
for chikungunya in Allopathy, there is an increasing trend 
among people in Kerala turning to traditional Indian 
medicines especially Ayurveda. In comparative evaluation 
of different system of medicines and present scenario of 
chickungunya in Malabar, Kerala, in case of Ayurvedic 
medicine, questionnaire were distributed to 5 doctors and 
collected the feedback, regarding medicines, treatment 
available, diagnosis etc. The study reveals that many 
numbers of medicines were prescribed including Vilvadi 
Gulika, Sudarsanam Gulika, Amritarishta. Vettumaran 
gulika, Amruthotharam kashayam, Amruthadiguggulu 
(1 gm tds), Rasnaeranda kwatha churna (15 mL tds), 
Vanathulasi patra, Dhanvantaram Gutika etc. The recovery 
of the patients normally takes place within three days 
if it is in early stage. Most of the doctors assured that 
Ayurvedic system of medication and treatment could cure 
the patient at earlier period without much side effects, 
since the preparation are from natural source without 
any added artificial preservations or artificial excepients. 
All the doctors participated in the survey (100%) assured 
that Ayurvedic medicines were  more effective than other 
systems of medicines and they were aware about the efficacy 
and adverse effects of drugs used. The study revealed that 
the condition of chikungunya worsen in patients who have 
arthritis. One observation noted during the study is that 
there is a wide belief among people in Kerala that, the 
application of local herb Chromolaena odorata (Communist 
pacha in local language) can be used for the treatment of 
chickungunya especially in pain relief. Communist pacha is 
a local leaf available in Kerala, which is effective in treating 
joint pain. Most of the doctors were aware of this which 
is an additional therapy in chickungunya. Ayurveda is a 
system wherein the patients were asked to follow a strict diet 
regimen avoiding coffee, tea, cool drinks and other similar 
food materials which may interfere in the treatment status. 
Some practitioners of Ayurveda claim that a medicine called 
Panchathikta Kashayam can cure chikungunya. It is a very 
bitter drug. Ayurveda massage is also administered for 
joint pain relief. Herbs such as sacred basil (Tulsi), carrot 
and grapes are usually recommended as a relief for the 
pain and fever. Since these are natural herbs and vegetable 
there is no risk in trying them out. Ayurvedic treatment of 
chickungunya uses herbal drugs, but patients have to be 
very careful since there are a large number of unlicensed 
Ayurvedic practitioners and some of them are known to add 
steroids in medicines for quick benefit. Ayurvedic method 
of living offers a solution to the problems of viral fever and 
almost all types of diseases. Ayurveda attributes the reasons 
of spread of diseases to the pollution of air, water and land 
and its imbalances in the body. 
4.2. Homeopathic treatment of chikungunya 
  In the case of homeopathy, feedback was obtained from 
5 doctors. The treatment was symptomatic, provisional 
diagnosis was done and the patients were asked not to 
follow any other system of medicine during homeopathy 
treatment. Only 60% of the homeopathy doctors were aware 
about the efficacy and adverse effects of drugs used. Most 
of the doctors (100%) believe that homeopathic medicine 
can cure chickungunya completely. (Assessment is based 
on the feedback obtained from certain doctors in our 
locality, in other locality, doctors may be aware of adverse 
effects). Cardiac, respiratory and arthritis can worsen 
chickungunya according to homeopathic system. According 
to homeopathic experts effective drugs are available to 
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prevent as well as to speed up recovery from chikungunya. 
Eupatorium Perfoliatum Q (tincture, 3 to 5 drop doses) 
can prevent chikungunya infection. Other medicines 
prescribed for the disease include Pyroginum, Rhus tox, 
Cedron, Influenzinum, China, Arnica. Ledumpal, bryonia, 
Belladonna, Nuxvomica. Etc. The study reveals that these 
homeopathic medicines were very effective for relieving 
complaints during chickungunya. . The duration of illness 
was reduced. The study reveals that, homeopathic medicines 
were very effective and gave about 90-95% protection, and 
they were able to go to work in 2-3 days.
  Though the growing concern about chickungunya is 
increasing at logarithmic rate, day after day, month after 
month, more commitment and proper massive awareness 
campaign from the donors and states is needed for the 
successful mitigation of chikungunya. Different system of 
medicine has much to offer in preventing chickungunya, 
but the wide spreading of disease is going high in alarming 
rate in developing countries because of the population and 
polluted environment. Keeping an unpolluted surrounding 
and clean environment is vital in the disease management 
which lacks in our locality. 
  Compared to other systems of medicine, people in our 
locality prefer Ayurveda, since it is devoid of side effects 
and the cure rate is also very high with this system of 
medicine. The local herb communist pacha (Chromolaena 
odorata) which is a new finding can cure the chickungunya 
(Especially pain and swelling), and has good potential in the 
future. Ayurvedic experts should tap/exploit the potential 
of this herb, since people claim that it has curing effect and 
efficacy. Multispeciality hospitals tackle the chickungunya 
menace but the extend of participation in mitigating the 
chickungunya is less. From our study we found that in some 
places there is no proper documentation, even though there 
are proper guidelines framed by the relevant authorities. 
It can be concluded from the study that all the systems 
of medicine are equally important for the management of 
chickungunya. Additional effort in promoting the guidelines 
at local level and proper documentation helps to achieve the 
goal of curbing the chikungunya. It is high time to increase 
our efforts and promote these messages at grass root level 
which benefits the society/community as a whole.
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